Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis

Effect of Spironolactone on Left Ventricular Ejection Fraction and Volumes in Patients With Class I or II Heart Failure

(2010) Enrico Vizzardi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Effect of Aldosterone Antagonism With Eplerenone on Ventricular Remodeling in Patients With Mild-to-Moderate Heart Failure and Left Ventricular Systolic Dysfunction

(2010) James E. Udelson et al.   Circulation-Heart Failure

Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF)

(2010) Faiez Zannad et al.   EUROPEAN JOURNAL OF HEART FAILURE

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

(2010) Faiez Zannad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of canrenone on left ventricular mechanics in patients with mild systolic heart failure and metabolic syndrome: The AREA-in-CHF study

(2010) G. de Simone et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial†

(2009) Chris Adamopoulos et al.   EUROPEAN JOURNAL OF HEART FAILURE

Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results

(2009) Alessandro Boccanelli et al.   EUROPEAN JOURNAL OF HEART FAILURE

Serum Potassium and Clinical Outcomes in the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)

(2008) Bertram Pitt et al.   CIRCULATION